{
  "actions": [
    {
      "acted_at": "2019-09-27",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-09-27",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2019-09-30",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4553-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "F000449",
      "district": "1",
      "name": "Fortenberry, Jeff",
      "original_cosponsor": true,
      "sponsored_at": "2019-09-27",
      "state": "NE",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001198",
      "district": "1",
      "name": "Marshall, Roger",
      "original_cosponsor": true,
      "sponsored_at": "2019-09-27",
      "state": "KS",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001213",
      "district": "1",
      "name": "Steil, Bryan",
      "original_cosponsor": false,
      "sponsored_at": "2019-10-31",
      "state": "WI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "V000131",
      "district": "33",
      "name": "Veasey, Marc A.",
      "original_cosponsor": true,
      "sponsored_at": "2019-09-27",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-09-27",
  "number": "4553",
  "official_title": "To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome, Nipah, and Rift Valley fever.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act",
  "sponsor": {
    "bioguide_id": "B001296",
    "district": "2",
    "name": "Boyle, Brendan F.",
    "state": "PA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-09-27",
  "subjects": [
    "Cardiovascular and respiratory health",
    "Drug safety, medical device, and laboratory regulation",
    "Drug therapy",
    "Health",
    "Infectious and parasitic diseases"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-09-27",
    "date": "2020-12-18T15:54:02Z",
    "text": "Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act\n\nThis bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome, Nipah, and Rift Valley fever.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-11-01T13:49:45Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4553.xml"
}